GovBidScope
15 days left to respond

Preclinical Assessment of Naloxone Adequacy to Reverse Polysubstance Use-Induced Respiratory Depression — In Vivo Validation

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNo Set aside used

Plain-English Summary

The Health And Human Services is looking for preclinical assessment of naloxone adequacy to reverse polysubstance use-induced respiratory depression — in vivo validation. This is a no set aside used contract, meaning only qualifying small businesses can bid. Responses are due in 15 days (September 10, 2026).

Contract Details

Solicitation #
75F40126Q00382
Type
Presolicitation
NAICS Code
541714
PSC Code
AN12
Posted
August 26, 2026
Response Deadline
September 10, 2026

Agency & Contact

Department
HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Sub-agency
FOOD AND DRUG ADMINISTRATION
Office
FDA OFFICE OF ACQ GRANT SVCS
Point of Contact
Kimberly Pennix
kimberly.pennix@fda.hhs.gov
2404029703
Ian Weiss
Ian.Weiss@fda.hhs.gov
3017965728

Who Should Bid

  • Businesses classified under NAICS 541714
  • Businesses qualifying for No Set aside used
  • Must be registered in SAM.gov with active status
  • Must have relevant past performance or capability statement

Tips for Winning This Contract

  • You have time to prepare a thorough response — use it for teaming arrangements or subcontracting
  • Contact the contracting officer with questions BEFORE the deadline — they want to help qualified bidders
  • Review the full solicitation documents on SAM.gov for detailed requirements
  • Check if there's an industry day or Q&A session listed
View Full Solicitation on SAM.gov

Download attachments, full requirements, and submit your response on SAM.gov

Similar Opportunities